Difference In Clinical & Biochemical Profile In Patients Of Long Standing Diabetes Having Diabetic Retinopathy & Patients Who Do Not Have Diabetic Retinopathy With Special Reference To Serum Bilirubin
DOI:
https://doi.org/10.52783/jns.v14.2795Keywords:
TYPE 2 DIABETES, BILIRUBIN, RETINOPATHY, HBA1CAbstract
e nanosized-based carrier systems which comprise solid lipid matrix combined with liquid lipids and surfactants. The aim of Diabetic retinopathy (DR) is a common complication of long-standing diabetes mellitus (DM) and is a leading cause of vision loss worldwide. Mounting evidence suggests that the presence of DR may be associated with alterations in various clinical and biochemical parameters, including serum bilirubin levels. This paper aims to explore the differences in the clinical and biochemical profiles of patients with long-standing DM, with and without DR, with a specific focus on serum bilirubin.
Purpose: To study the association between serum bilirubin concentration and different grades of diabetic retinopathy in patients with type-2 diabetes mellitus
Settings and Design: Cross sectional (observational) study
Materials and Methods: A cross-sectional (observational) study was conducted among patients with duration of diabetes more than or equal to 3 years. Seventy-six eligible patients were undergone complete ophthalmic evaluation along with detailed Ocular and medical history followed by examination and measurements as described above. Diabetic gradings were done according to International Clinical Disease Severity Scale. All patients were grouped as without and with diabetic retinopathy changes using Early Treatment of Diabetic Retinopathy Study (ETDRS) classification. All patients were investigated to assess their glycaemic control (RBS and HbA1c) and serum bilirubin levels (Diazo method). Findings were recorded in a pre-designed proforma and analysed for relationship of biochemical parameters with various stages of diabetic retinopathy
Results: The mean age of the study participants was 59.72 years. Among 7.9% had a duration of diabetes of more than ten years. 55.3% of the study participants had a duration of diabetes less than five years. In the present study, the mean total bilirubin was 0.58 mg/dl among diabetic patients. The mean values of direct and indirect bilirubin were 0.34 mg/dl (SD -0.14mg/dl) and 0.24 mg/dl (SD- 0.07 mg/dl), respectively.
Conclusion: The proportion of diabetic retinopathy was significantly higher with long duration of diabetes. The mean values of total bilirubin, direct bilirubin and indirect bilirubin were significantly higher among the patients with no diabetic retinopathy compare to patients having diabetic retinopathy. Independent of conventional risk variables, low blood bilirubin concentrations were significantl related with an elevated risk of DR. Serum bilirubin may be used as a biomarker to identify persons at risk for DR.
Downloads
References
Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmology 2021; 69:2932-8.
International Diabetes Federation, Diabetes Atlas. 6th ed. 2013. Available from: http://www.idf.org/diabetesatlas.
Murthy GV, Sundar G, Gilbert C, Shukla R. Operational guidelines for diabetic retinopathy in India: Summary. Indian J Ophthalmol 2020; 68:S59-62
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35:556-64.
Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology 2009; 116:311-8.
Do DV, Wang X, Vedula SS, Marrone M, Sleilati G, Hawkins BS, et al. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev 2015;1:CD006127.
Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2013;11:CD008143.
Jung CH, Lee MJ, Kang YM, et al. Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men: a 4-year retrospective longitudinal study. Metabolism 2014;63(1):87-93.
Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987; 235: 1043–1046.
Stocker R, Glazer AN, Ames BN. Antioxidant activity of albuminbound bilirubin. Proc Natl Acad Sci U S A. 1987; 84: 59.
Yasuda M, Kiyohara Y, Wang JJ, Arakawa S, Yonemoto K, Doi Y, Ninomiya T, Ishibashi T. High serum bilirubin levels and diabetic retinopathy: the Hisayama Study Ophthalmology 2011; 118(7):1423-8
Fukui M, Tanaka M, Shiraishi E, et al. Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int 2008;74(9):1197-201.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
